GlaxoSmithKline PLC ADR

Yahoo Finance • 6 days ago

Hepatitis A Market Research Report 2026-2036: Ecosystem, Marketed and Emerging Therapies, Epidemiological Analysis, Pipeline, Clinical Trial Landscape, Regulations Featuring GSK, Merck, and Sanofi

Company Logo The global Hepatitis A vaccine market is expanding due to increased disease awareness, government immunization initiatives, and rising international travel. Countries worldwide are implementing vaccination programs, bolsterin... Full story

Yahoo Finance • 9 days ago

Hepatic Cirrhosis Market Research and Forecast Report 2026-2036, Profiles of Abbott, Astellas Pharma, Gilead Sciences, Novartis, Takeda Pharma, Grifols Therapeutics, and Cellaion

Company Logo The global hepatic cirrhosis market is expanding rapidly, fueled by increasing liver disease cases, advanced treatment options, and improved healthcare infrastructure. Conditions like hepatitis, alcohol abuse, and metabolic d... Full story

Yahoo Finance • 12 days ago

FDA leadership fallout continues as acting CDER Director Hoeg expected to depart

[FDA headquarters in Washington DC.] JHVEPhoto * Just days after Marty Makary left [https://seekingalpha.com/news/4591441-fda-commissioner-makary-getting-fired-tuesday] as FDA commissioner on May 12, Tracey Beth Hoeg, the acting leader... Full story

Yahoo Finance • 15 days ago

European Equities Traded in the US as American Depositary Receipts Decline Sharply in Tuesday Trading

European equities traded in the US as American depositary receipts were down significantly late Tues PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 16 days ago

Sotrovimab (Xevudy: Vir Biotechnology, GlaxoSmithKline) Market Research Report 2026: Epidemiology, Pipeline Analysis, Insights & Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, May 11, 2026 (GLOBE NEWSWIRE) -- The "Sotrovimab or Xevudy Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. The report offers invaluable insi... Full story

Yahoo Finance • 19 days ago

Trump says unaware of a plan to fire FDA commissioner

Anna Moneymaker/Getty Images News Amid multiple reports suggesting that President Donald Trump has signed off on a plan to oust FDA commissioner Marty Makary, Trump said late Friday that he is completely unaware of such a proposal. The W... Full story

Yahoo Finance • 22 days ago

Medable CEO Michelle Longmire Featured as Guest Speaker with Leaders from Google and Mayo Clinic at Japan’s Largest Pharmaceutical Summit

Agentic AI the focus of innovation in Japan’s rapidly growing clinical research landscape PALO ALTO, Calif., May 06, 2026--(BUSINESS WIRE)--Medable Inc., the leading technology platform for agentic AI clinical development, today announced... Full story

Yahoo Finance • 28 days ago

European Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading

European equities traded in the US as American depositary receipts were lower late Wednesday morning PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 29 days ago

Shot in the arm for GSK and AstraZeneca from cancer drug sales

Drug giants GSK and AstraZeneca have revealed better-than-forecast first quarter profits thanks to strong sales for cancer treatments. AstraZeneca notched up a 12% hike in operating profits to 4.25 billion US dollars (£3.14 billion) in th... Full story

Yahoo Finance • 29 days ago

‘American industry is winning’: White House touts factory boom — how investors can ride the reshoring wave

Moneywise and Yahoo Finance LLC may earn commission or revenue through links in the content below. American manufacturing is back, and it's better than ever. In a new White House press release (1), officials point to a string of improving... Full story

Yahoo Finance • 30 days ago

Human Papillomavirus Market Research Report 2025-2035, Competitive Analysis of Key Players - GlaxoSmithKline, Merck, and Serum Institute of India

Company Logo The Human Papillomavirus (HPV) market is in a growth phase, driven by high vaccine adoption and innovative therapeutic strategies targeting HPV-related cancers like cervical and oropharyngeal. Key drivers include advancements... Full story

Yahoo Finance • last month

Monetizr Appoints Veteran Growth Strategist Michelle Suttle as Chief Growth Officer to Accelerate Growth in a New Era of Media

Monetizr today announced the appointment of Michelle Suttle as Chief Growth Officer, bringing on a seasoned growth leader as brands look for more effective ways to reach consumers beyond traditional digital channels. Suttle joins Monetizr... Full story

Yahoo Finance • last month

Oncology Clinical Trials Research Report 2026: $20+ Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, April 24, 2026 (GLOBE NEWSWIRE) -- The "Oncology Clinical Trials Market Report 2026" has been added to ResearchAndMarkets.com's offering. The oncology clinical trials market has seen substantial growth, transitioning from $14.9... Full story

Yahoo Finance • last month

Ribonucleic Acid (RNA) Therapy Clinical Trials Research Report 2026: $3.4 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, April 24, 2026 (GLOBE NEWSWIRE) -- The "Ribonucleic Acid (RNA) Therapy Clinical Trials Market Report 2026" has been added to ResearchAndMarkets.com's offering. The RNA therapy clinical trials market is witnessing steady growth,... Full story

Yahoo Finance • last month

Chronic Obstructive Pulmonary Disease Clinical Trial Landscape Expands: Over 65 Companies Advancing Next-Generation Therapies | DelveInsight

New York, USA, April 23, 2026 (GLOBE NEWSWIRE) -- Chronic Obstructive Pulmonary Disease Clinical Trial Landscape Expands: Over 65 Companies Advancing Next-Generation Therapies | DelveInsight The chronic obstructive pulmonary disease cli... Full story

Yahoo Finance • last month

GSK Respiratory Breakthrough And Pipeline Advances Reshape Long Term Outlook

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. GSK (LSE:GSK) secured multi region regulatory approvals in China a... Full story

Yahoo Finance • last month

European Equities Traded in the US as American Depositary Receipts Declining in Thursday Trading

European equities traded in the US as American depositary receipts were trending lower late Thursday PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • last month

Sector Update: Health Care Stocks Decline Late Afternoon

Health care stocks were lower late Wednesday afternoon, with the NYSE Health Care Index down 0.5% an PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • last month

GSK Plans Five Late-Stage Cancer Trials As Shares Rise Nearly 50%

This article first appeared on GuruFocus. GSK (NYSE:GSK) is beginning to show a more assertive shift in strategy as CEO Luke Miels pushes the company toward higher-risk oncology development, with plans to launch five simultaneous late-sta... Full story

Yahoo Finance • last month

Data Published in Nature Communications Highlights Unique Mechanism of Action of Alpibectir in Combination with Ethionamide (AlpE)

BASEL, Switzerland, April 13, 2026 (GLOBE NEWSWIRE) -- BioVersys and partners publish in the prestigious journal of Nature Communications pre-clinical development data of AlpE (alpibectir and ethionamide), an innovative drug combination... Full story